387 related articles for article (PubMed ID: 12219256)
1. [Relevance of the pseudoexfoliation syndrome for the glaucomas].
Schlötzer-Schrehardt U; Küchle M; Jünemann A; Naumann GO
Ophthalmologe; 2002 Sep; 99(9):683-90. PubMed ID: 12219256
[TBL] [Abstract][Full Text] [Related]
2. Trabecular meshwork in pseudoexfoliation syndrome with and without open-angle glaucoma. A morphometric, ultrastructural study.
Schlötzer-Schrehardt U; Naumann GO
Invest Ophthalmol Vis Sci; 1995 Aug; 36(9):1750-64. PubMed ID: 7635652
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of TGF-beta 1 and TGF-beta 2 on extracellular matrix production, proliferation, migration, and collagen contraction of human Tenon's capsule fibroblasts in pseudoexfoliation and primary open-angle glaucoma.
Kottler UB; Jünemann AG; Aigner T; Zenkel M; Rummelt C; Schlötzer-Schrehardt U
Exp Eye Res; 2005 Jan; 80(1):121-34. PubMed ID: 15652533
[TBL] [Abstract][Full Text] [Related]
4. Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material.
Zenkel M; Kruse FE; Jünemann AG; Naumann GO; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2006 May; 47(5):1982-90. PubMed ID: 16639006
[TBL] [Abstract][Full Text] [Related]
5. Pseudoexfoliation syndrome for the comprehensive ophthalmologist. Intraocular and systemic manifestations.
Naumann GO; Schlötzer-Schrehardt U; Küchle M
Ophthalmology; 1998 Jun; 105(6):951-68. PubMed ID: 9627642
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathology of pseudoexfoliation syndrome/glaucoma--new insights from LOXL1 gene associations.
Schlötzer-Schrehardt U
Exp Eye Res; 2009 Apr; 88(4):776-85. PubMed ID: 18809397
[TBL] [Abstract][Full Text] [Related]
7. [New pathogenetic insights into pseudoexfoliation syndrome/glaucoma. Therapeutically relevant?].
Schlötzer-Schrehardt U
Ophthalmologe; 2012 Oct; 109(10):944-51. PubMed ID: 23053330
[TBL] [Abstract][Full Text] [Related]
8. Ocular and systemic pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Naumann GO
Am J Ophthalmol; 2006 May; 141(5):921-937. PubMed ID: 16678509
[TBL] [Abstract][Full Text] [Related]
9. Differential gene expression in pseudoexfoliation syndrome.
Zenkel M; Pöschl E; von der Mark K; Hofmann-Rummelt C; Naumann GO; Kruse FE; Schlötzer-Schrehardt U
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3742-52. PubMed ID: 16186358
[TBL] [Abstract][Full Text] [Related]
10. Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome.
Gottanka J; Flügel-Koch C; Martus P; Johnson DH; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2435-46. PubMed ID: 9375560
[TBL] [Abstract][Full Text] [Related]
11. [Oxidative stress and pseudoexfoliation glaucoma].
Schlötzer-Schrehardt U
Klin Monbl Augenheilkd; 2010 Feb; 227(2):108-13. PubMed ID: 20155654
[TBL] [Abstract][Full Text] [Related]
12. What increases outflow resistance in primary open-angle glaucoma?
Tamm ER; Fuchshofer R
Surv Ophthalmol; 2007 Nov; 52 Suppl 2():S101-4. PubMed ID: 17998032
[TBL] [Abstract][Full Text] [Related]
13. [Pseudoexfoliation syndrome (PEX)--a systemic disorder].
Kurowska AK; Kamińska A; Izdebska J; Szaflik JP; Szaflik J
Klin Oczna; 2009; 111(4-6):160-4. PubMed ID: 19673450
[TBL] [Abstract][Full Text] [Related]
14. [Latent TGF-beta 1 binding protein (LTBP-1); a new marker for intra-and extraocular PEX deposits].
Schlötzer-Schrehardt U; Küchle M; Hofmann-Rummelt C; Kaiser A; Kirchner T
Klin Monbl Augenheilkd; 2000 Jun; 216(6):412-9. PubMed ID: 10919121
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta1, matrix-metalloproteinase-2 and its tissue inhibitor in patients with pseudoexfoliation glaucoma/syndrome.
Djordjević-Jocić J; Zlatanović G; Veselinović D; Jovanović P; Djordjević V; Zvezdanović L; Stanković-Babić G; Vujanović M; Cekić S; Zenkel M; Schlotzer-Schrehardt U
Vojnosanit Pregl; 2012 Mar; 69(3):231-6. PubMed ID: 22624408
[TBL] [Abstract][Full Text] [Related]
16. Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study.
Hammer T; Schlötzer-Schrehardt U; Naumann GO
Arch Ophthalmol; 2001 Jul; 119(7):1023-31. PubMed ID: 11448324
[TBL] [Abstract][Full Text] [Related]
17. [Pathogenesis and histopathology of pseudoexfoliative lesions. The eyeball disease or ocular manifestation of a generalized process?].
Lis GJ
Przegl Lek; 2006; 63(7):588-92. PubMed ID: 17203815
[TBL] [Abstract][Full Text] [Related]
18. Structural changes of the trabecular meshwork in different kinds of glaucoma.
Tektas OY; Lütjen-Drecoll E
Exp Eye Res; 2009 Apr; 88(4):769-75. PubMed ID: 19114037
[TBL] [Abstract][Full Text] [Related]
19. Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome.
Schlötzer-Schrehardt U; Zenkel M; Küchle M; Sakai LY; Naumann GO
Exp Eye Res; 2001 Dec; 73(6):765-80. PubMed ID: 11846508
[TBL] [Abstract][Full Text] [Related]
20. The management of exfoliative glaucoma.
Ritch R
Prog Brain Res; 2008; 173():211-24. PubMed ID: 18929111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
